Interferon-γ (IFN-γ)

A possible prognostic marker for clearance of high-risk human papillomavirus (HPV)

Seung Hun Song, Jae Kwan Lee, Nak Woo Lee, Ho Suk Saw, Jae Sung Kang, Kyu Wan Lee

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Objectives.: The goal of this study was to identify cytokines that may predict high-risk HPV clearance or persistence in untreated patients with mild dysplasia or less of the uterine cervix. Methods.: A prospective analysis was performed on 57 patients who harbored high-risk HPV with histologically verified mild dysplasia or less between May 2005 and March 2006. All patients underwent follow-up evaluation at 12 months. Real-time PCR was used to quantify interferon-γ (IFN-γ), interleukin-10 (IL-10), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) transcripts. Hybrid Capture II testing was used to detect HPV DNA. Results.: Among the 57 patients that were untreated with mild dysplasia, or less, 46 (80.7%) had no detectable HPV after 12 months of follow-up. Univariate analysis showed that a negative HPV test, of untreated mild dysplasia or less, occurred in 93.3% (28/30) of patients who were IFN-γ-positive and in 66.7% (18/27) of patients who were IFN-γ-negative (P = 0.0109). Other factors such as age, lesion grade in the colposcopic biopsy, IL-10, IL-6, TNF-α, day of menstrual cycle, smoking, and use of oral contraceptives were not significantly associated with high-risk HPV negative or positive results after 12-months of follow-up in patients with untreated mild dysplasia or less. The multivariate logistic regression analysis showed that only IFN-γ-positive results were significantly associated with clearance of high-risk HPV after 12 months of follow-up (OR: 8.26; 95% CI: 1.24-54.94). Conclusions.: These results suggest that intralesional IFN-γ may be a prognostic marker for clearance of high-risk HPV.

Original languageEnglish
Pages (from-to)543-548
Number of pages6
JournalGynecologic Oncology
Volume108
DOIs
Publication statusPublished - 2008 Mar 1

Fingerprint

Interferons
Interleukin-10
Interleukin-6
Tumor Necrosis Factor-alpha
Menstrual Cycle
Oral Contraceptives
Cervix Uteri
Real-Time Polymerase Chain Reaction
Logistic Models
Smoking
Regression Analysis
Cytokines
Biopsy
DNA

Keywords

  • Human papillomavirus (HPV)
  • Interferon-γ (IFN-γ)
  • Interleukin-10 (IL-10)
  • Interleukin-6 (IL-6)
  • Tumor necrosis factor-α (TNF-α)

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Interferon-γ (IFN-γ) : A possible prognostic marker for clearance of high-risk human papillomavirus (HPV). / Song, Seung Hun; Lee, Jae Kwan; Lee, Nak Woo; Saw, Ho Suk; Kang, Jae Sung; Lee, Kyu Wan.

In: Gynecologic Oncology, Vol. 108, 01.03.2008, p. 543-548.

Research output: Contribution to journalArticle

@article{caddadff994945e883d60523d3c12d00,
title = "Interferon-γ (IFN-γ): A possible prognostic marker for clearance of high-risk human papillomavirus (HPV)",
abstract = "Objectives.: The goal of this study was to identify cytokines that may predict high-risk HPV clearance or persistence in untreated patients with mild dysplasia or less of the uterine cervix. Methods.: A prospective analysis was performed on 57 patients who harbored high-risk HPV with histologically verified mild dysplasia or less between May 2005 and March 2006. All patients underwent follow-up evaluation at 12 months. Real-time PCR was used to quantify interferon-γ (IFN-γ), interleukin-10 (IL-10), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) transcripts. Hybrid Capture II testing was used to detect HPV DNA. Results.: Among the 57 patients that were untreated with mild dysplasia, or less, 46 (80.7{\%}) had no detectable HPV after 12 months of follow-up. Univariate analysis showed that a negative HPV test, of untreated mild dysplasia or less, occurred in 93.3{\%} (28/30) of patients who were IFN-γ-positive and in 66.7{\%} (18/27) of patients who were IFN-γ-negative (P = 0.0109). Other factors such as age, lesion grade in the colposcopic biopsy, IL-10, IL-6, TNF-α, day of menstrual cycle, smoking, and use of oral contraceptives were not significantly associated with high-risk HPV negative or positive results after 12-months of follow-up in patients with untreated mild dysplasia or less. The multivariate logistic regression analysis showed that only IFN-γ-positive results were significantly associated with clearance of high-risk HPV after 12 months of follow-up (OR: 8.26; 95{\%} CI: 1.24-54.94). Conclusions.: These results suggest that intralesional IFN-γ may be a prognostic marker for clearance of high-risk HPV.",
keywords = "Human papillomavirus (HPV), Interferon-γ (IFN-γ), Interleukin-10 (IL-10), Interleukin-6 (IL-6), Tumor necrosis factor-α (TNF-α)",
author = "Song, {Seung Hun} and Lee, {Jae Kwan} and Lee, {Nak Woo} and Saw, {Ho Suk} and Kang, {Jae Sung} and Lee, {Kyu Wan}",
year = "2008",
month = "3",
day = "1",
doi = "10.1016/j.ygyno.2007.11.006",
language = "English",
volume = "108",
pages = "543--548",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Interferon-γ (IFN-γ)

T2 - A possible prognostic marker for clearance of high-risk human papillomavirus (HPV)

AU - Song, Seung Hun

AU - Lee, Jae Kwan

AU - Lee, Nak Woo

AU - Saw, Ho Suk

AU - Kang, Jae Sung

AU - Lee, Kyu Wan

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Objectives.: The goal of this study was to identify cytokines that may predict high-risk HPV clearance or persistence in untreated patients with mild dysplasia or less of the uterine cervix. Methods.: A prospective analysis was performed on 57 patients who harbored high-risk HPV with histologically verified mild dysplasia or less between May 2005 and March 2006. All patients underwent follow-up evaluation at 12 months. Real-time PCR was used to quantify interferon-γ (IFN-γ), interleukin-10 (IL-10), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) transcripts. Hybrid Capture II testing was used to detect HPV DNA. Results.: Among the 57 patients that were untreated with mild dysplasia, or less, 46 (80.7%) had no detectable HPV after 12 months of follow-up. Univariate analysis showed that a negative HPV test, of untreated mild dysplasia or less, occurred in 93.3% (28/30) of patients who were IFN-γ-positive and in 66.7% (18/27) of patients who were IFN-γ-negative (P = 0.0109). Other factors such as age, lesion grade in the colposcopic biopsy, IL-10, IL-6, TNF-α, day of menstrual cycle, smoking, and use of oral contraceptives were not significantly associated with high-risk HPV negative or positive results after 12-months of follow-up in patients with untreated mild dysplasia or less. The multivariate logistic regression analysis showed that only IFN-γ-positive results were significantly associated with clearance of high-risk HPV after 12 months of follow-up (OR: 8.26; 95% CI: 1.24-54.94). Conclusions.: These results suggest that intralesional IFN-γ may be a prognostic marker for clearance of high-risk HPV.

AB - Objectives.: The goal of this study was to identify cytokines that may predict high-risk HPV clearance or persistence in untreated patients with mild dysplasia or less of the uterine cervix. Methods.: A prospective analysis was performed on 57 patients who harbored high-risk HPV with histologically verified mild dysplasia or less between May 2005 and March 2006. All patients underwent follow-up evaluation at 12 months. Real-time PCR was used to quantify interferon-γ (IFN-γ), interleukin-10 (IL-10), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) transcripts. Hybrid Capture II testing was used to detect HPV DNA. Results.: Among the 57 patients that were untreated with mild dysplasia, or less, 46 (80.7%) had no detectable HPV after 12 months of follow-up. Univariate analysis showed that a negative HPV test, of untreated mild dysplasia or less, occurred in 93.3% (28/30) of patients who were IFN-γ-positive and in 66.7% (18/27) of patients who were IFN-γ-negative (P = 0.0109). Other factors such as age, lesion grade in the colposcopic biopsy, IL-10, IL-6, TNF-α, day of menstrual cycle, smoking, and use of oral contraceptives were not significantly associated with high-risk HPV negative or positive results after 12-months of follow-up in patients with untreated mild dysplasia or less. The multivariate logistic regression analysis showed that only IFN-γ-positive results were significantly associated with clearance of high-risk HPV after 12 months of follow-up (OR: 8.26; 95% CI: 1.24-54.94). Conclusions.: These results suggest that intralesional IFN-γ may be a prognostic marker for clearance of high-risk HPV.

KW - Human papillomavirus (HPV)

KW - Interferon-γ (IFN-γ)

KW - Interleukin-10 (IL-10)

KW - Interleukin-6 (IL-6)

KW - Tumor necrosis factor-α (TNF-α)

UR - http://www.scopus.com/inward/record.url?scp=39249085187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39249085187&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2007.11.006

DO - 10.1016/j.ygyno.2007.11.006

M3 - Article

VL - 108

SP - 543

EP - 548

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

ER -